Springer eBooks may be purchased by end-customers only and are sold without copy protection (DRM free). Instead, all eBooks include personalized watermarks. This means you can read the Springer eBooks across numerous devices such as Laptops, eReaders, and tablets.
You can pay for Springer eBooks with Visa, Mastercard, American Express or Paypal.
After the purchase you can directly download the eBook file or read it online in our Springer eBook Reader. Furthermore your eBook will be stored in your MySpringer account. So you can always re-download your eBooks.
Focuses on the full spectrum of disease from current molecular and genetic hypotheses regarding risk and progression
Authors will represent a broad spectrum of opinion and expertise in the prostate cancer community
Provide an updated, concise overview of major themes and controversies in the epidemiology, diagnosis, and management of prostate cancer
The thoroughly updated and revised third edition of Management of Prostate Cancer provides concise and authoritative guidance to today's best therapeutic regimens for the diagnosis and treatment of prostate cancer. Highlighting the latest major advances in the field, the bookincludes chapters on the most controversial areas of prostate cancer – screening, chemoprevention, and active surveillance; updated chapters on genetic risk and progression, biopsy schemes, treatment of complications, and comparative treatment outcomes for surgery; and new chapters on risk factors, new markers, nomograms, and focal therapy. This volume also features overviews of new and emerging drugs and treatment paradigms for castrate resistant disease, advances that promise to extend life and perhaps even cure a subset of men with metastatic disease.
With its comprehensive illustrations and contributions from renowned experts in the field, Management of Prostate Cancer, 3rd Edition is an invaluable resource for practitioners in the treatment of prostate cancer.
1 Epidemiology and Risk Factors Ranko Miocinovic 2 Twenty years and counting: is PSA still useful in 2010? Haluk Ozen Sertac Yazici 3 Prostate Cancer Screening: A Review of the Evidence with Clinical Practice Implications Timothy J Wilt 4 Beyond PSA: Promising New Markers for Prostate Cancer Leonard Marks 5 Hereditary Prostate Cancer and Genetic Risk Adam C Reese Graham Casey John S Witte 6 Prostate Inflammation and Prostate Cancer William G. Nelson Karen S. Sfanos Angelo M. DeMarzo Srinivasan Yegnasubramanian 7 Molecular Progression of Prostate Cancer: Androgens and Estrogens Stephen A. Boorjian Donald J Tindall 8 The Role of Obesity and Diet in Prostate Cancer Jean-Alfred Thomas, II Stephen J Freedland 9 Prostate Cancer Risk Reduction by Chemoprevention Kenneth G. Nepple Adam S. Kibel Gerald L Andriole 10 Current Issues in Pathologic Evaluation Sara M. Falzarano Howard S. Levin Cristina Magi-Galluzzi 11 Optimum Prostate Biopsy: Technique and Strategies Osama M. Zaytoun J. Stephen Jones 12 The Utility of Nomograms in Routine Clinical Practice Carvell T. Nguyen Michael W. Kattan 13 Active Surveillance Comes of Age Laurence Klotz 14 Focal Therapy: Prostate Hemiablation as the First Historical Treatment Model for Focal Therapy of Early Stage Prostate Cancer Vladimir Mouraviev Thomas J Polascik 15 Contemporary External Beam Radiotherapy Rahul Tendulkahr Kevin Stephans 16 Surgery, Brachytherapy, or External Beam Radiation for Low and Intermediate-Risk Disease? Jay P Ciezki Eric A Klein 17 The Role for Radical Prostatectomy in Advanced Prostate Cancer R. Jeffrey Karnes Michael L Blute18 Radiation Therapy in the Management of Locally Advanced Prostate Cancer Joseph D Mancias Anthony L Zeitman 19 Clinical Implications of Measuring Quality-of-Life in Early Stage Prostate Cancer Peter Chang Mehrdad Alemozaffar Martin G Sanda 20 Treatment Modalities of Post-Prostatectomy Incontinence: A Historical Perspective As Well As Current Therapy Options Christina Ching Drogo K. Montague 21 Management of Biochemical Recurrence After Localized Treatment for Prostate Cancer Stephen B. Williams Toni K. Choueiri 22 Management of Newly Diagnosed Metastatic Disease C. Lance Cowey Thomas E Hutson 23 Pitfalls of Androgen Deprivation Therapy Alicia K Morgans Matthew R Smith 24 Current Management of Castration-resistant Prostate Cancer (CRPC) Jorge A Garcia Robert Dreicer 25 Radiopharmaceuticals and Bone Metastasis Oliver Sartor